Literature DB >> 9352250

Influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects.

A M Grandi1, G Gaudio, A Fachinetti, P Zanzi, L Bianchi, L Ceriani, L Guasti, A Venco.   

Abstract

We evaluated the influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects (H): 40 lean [body mass index (BMI) < or = 25 kg m-2] H with normotensive parents (F-), 50 lean H with one or two parents hypertensive (F+), 30 obese HF- (BMI > or = 30 kg m-2) and 35 obese HF+. The four groups were comparable in terms of age, sex and ambulatory blood pressure values. We evaluated glucose, insulin and C-peptide before and 30, 60, 90 and 120 min after an oral glucose load, insulin sensitivity index (ISI, fasting glucose/insulin ratio), fasting insulin/C-peptide ratio (I/Cp). Glucose, fasting and during test, and I/Cp were similar among the four groups; insulin and C-peptide, fasting and stimulated, were significantly higher and ISI lower in obese H than in lean H; at similar BMI, insulin and C-peptide were significantly higher in F+ than in F-. Insulin directly correlated with night-time blood pressure only in lean HF-. The correlation between insulin and BMI was significantly closer in F-than in F+. In conclusion, family history of hypertension appears to play a relevant role in insulin sensitivity in hypertensive subjects also in the presence of obesity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352250     DOI: 10.1046/j.1365-2362.1997.1700725.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  1 in total

1.  Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.

Authors:  I-Te Lee; Yen-Feng Chiu; Chii-Min Hwu; Chih-Tsueng He; Fu-Tien Chiang; Yu-Chun Lin; Themistocles Assimes; J David Curb; Wayne H-H Sheu
Journal:  Cardiovasc Diabetol       Date:  2012-04-26       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.